30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Healthcare Sector Insider Trading Activity

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 3,186 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière (USDm) # acheteurs nets Valeur nette ($) % du flottant acheté % d'actions détenues par les initiés
Healthcare Services Mid (5.8bn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (5.7bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.6bn) -1–5 -$100M+ -0–15% 0–15%
DK H Lundbeck A/S (HLUN-A)
Pharmaceuticals & Medical Research Mid (5.6bn) 0 Aucune activité — 0–15%
SE Getinge AB (GETI-B)
Healthcare Services Mid (5.5bn) 1–5 $10M–$100M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (5.5bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (5.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (5.3bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (5.3bn) -1–5 -$100K–$1M -0–15% 15–50%
US LHC Group Inc (LHCG)
Healthcare Services Mid (5.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (5.2bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (5.0bn) 0 Aucune activité — 15–50%
GB Indivior PLC (INDV)
Pharmaceuticals & Medical Research Mid (4.9bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (4.7bn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Mid (4.7bn) 0 Aucune activité — 0–15%
US Veracyte Inc (VCYT)
Pharmaceuticals & Medical Research Mid (4.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (4.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
US LivaNova PLC (LIVN)
Healthcare Services Mid (4.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.4bn) 0 Aucune activité — 50%+
Healthcare Services Mid (4.4bn) 0 -< $100K 0–15% 0–15%
Healthcare Services Mid (4.4bn) -1–5 -$100M+ -15–50% 0–15%
Healthcare Services Mid (4.4bn) 0 Aucune activité — 50%+
US Erasca Inc (ERAS)
Pharmaceuticals & Medical Research Mid (4.4bn) 0 Aucune activité — 0–15%
US Celcuity Inc (CELC)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.3bn) 1–5 $100K–$1M 0–15% 15–50%
IN Biocon Ltd (BIOCON)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (4.2bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (4.2bn) 0 Aucune activité — 0–15%
US RadNet Inc (RDNT)
Healthcare Services Mid (4.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Alkermes Inc (ALKS)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 0–15%
US TESARO Inc (TSRO)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — —
US Metsera Inc (MTSR)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 0–15%
IN Ajanta Pharma Ltd (AJANTPHARM)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (4.1bn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (4.0bn) -1–5 -< $100K -0–15% 50%+
Pharmaceuticals & Medical Research Mid (3.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.8bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Mid (3.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Perrigo Co (PRGO)
Pharmaceuticals & Medical Research Mid (3.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.7bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (3.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (3.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.6bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (3.6bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.5bn) -1–5 -< $100K -0–15% 0–15%
US Organon & Co (OGN)
Pharmaceuticals & Medical Research Mid (3.5bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 Aucune activité — 50%+
Healthcare Services Mid (3.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.5bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 $100K–$1M 0–15% 0–15%
Healthcare Services Mid (3.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (3.4bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.4bn) 0 Aucune activité — 15–50%
SE Medicover AB (MCOV-B)
Healthcare Services Mid (3.4bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Mid (3.3bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.3bn) 0 Aucune activité — 0–15%
US Amedisys Inc (AMED)
Healthcare Services Mid (3.3bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.3bn) 0 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (3.2bn) -1–5 -< $100K -0–15% 0–15%
FR Virbac SA (VIRP)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 50%+
SE BioArctic AB (BIOA-B)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (3.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 1–5 $10M–$100M 0–15% 50%+
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 50%+
Healthcare Services Mid (3.2bn) -1–5 -$1M–$10M -0–15% 15–50%
Healthcare Services Mid (3.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.1bn) -1–5 -$100K–$1M -0–15% 0–15%